Short reportsEnhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism?
References (12)
Pathophysiology of chronic heart failure
Lancet
(1992)- et al.
Endothelial function in chronic congestive heart failure
Am J Cardiol
(1992) Statistical analysis of Veterans Administration Vasodilator Heart Failure Trial results
Am J Cardiol
(1990)- et al.
Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells
Biochem Biophys Res Commun
(1993) - et al.
Nitric oxide synthase activities in human myocardium
Lancet
(1993)
There are more references available in the full text version of this article.
Cited by (128)
The pathophysiological role of interstitial sodium in heart failure
2015, Journal of the American College of CardiologyCitation Excerpt :It is well known that, compared with healthy subjects, endothelium-dependent NO-mediated vasodilation is impaired in skeletal muscle and in the coronary and pulmonary circulations of patients with chronic HF (65–67). Overall, the lack of NO increases vascular smooth muscle tone and consequently increases vascular resistance (68). Increased arteriolar resistance results in increased cardiac afterload, which often characterizes ADHF.
Right ventricular afterload and the role of nitric oxide metabolism in left-sided heart failure
2013, Journal of Cardiac FailureCardiovascular Biomarkers in Exhaled Breath
2012, Progress in Cardiovascular DiseasesAlterations in the Peripheral Circulation in Heart Failure
2011, Heart FailureAlterations in the Peripheral Circulation in Heart Failure
2010, Heart Failure: A Companion to Braunwald's Heart Disease Expert ConsultNitric oxide (NO) is a new clinical biomarker of survival in the elderly patients and its efficacy might be nearly equal to albumin
2007, Nitric Oxide - Biology and Chemistry
Copyright © 1994 Published by Elsevier Ltd.